NCT07032519

Brief Summary

The purpose of this pilot feasibility study is to evaluate the effects of a smartphone-based mindfulness intervention (MBI) on pain-related outcomes in individuals with fibromyalgia. This 8-week randomized controlled trial will compare an MBI app group to a control group who completes assessments only through the app. The MBI intervention includes weekly video content focused on mindfulness practice and psychoeducation, combined with daily symptom tracking through the app. Participants in both groups will complete self-report measures at baseline, post-intervention, and follow-ups at 3 and 6 months. The study will enroll up to 100 participants from Brigham and Women's Hospital and the greater Boston area. This pilot study is designed to assess feasibility and explore preliminary effects on outcomes such as pain interference, fibromyalgia symptoms, pain catastrophizing, sleep disturbance, emotional distress, mindfulness, and pain acceptance. Results will be used to inform the design of a future fully powered randomized trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 15, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 24, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

1.2 years

First QC Date

June 15, 2025

Last Update Submit

January 28, 2026

Conditions

Keywords

MindfulnessPainmHealthChronic Pain

Outcome Measures

Primary Outcomes (1)

  • Change in Brief Pain Inventory

    Assessed using the Brief Pain Inventory - Pain Interference Subscale

    Daily for 8-weeks

Secondary Outcomes (6)

  • Change in Fibromyalgia Symptoms (FIQR)

    Weekly for 8-weeks

  • Change in Pain Catastrophizing (PCS)

    Baseline and post (8 weeks)

  • Pain Acceptance (CPAQ-R)

    Baseline and post (8 weeks)

  • Mindfulness (MAAS)

    Baseline and post (8 weeks)

  • Anxiety and Depression (PROMIS-A/D)

    Baseline and post (8 weeks)

  • +1 more secondary outcomes

Study Arms (2)

Mindfulness-Based Intervention (MBI)

EXPERIMENTAL

Participants in this group will receive access to a smartphone app delivering an 8-week mindfulness-based intervention. The app includes weekly video modules (mindfulness practice and psychoeducation), daily pain tracking, and weekly assessments.

Behavioral: Mindfulness Intervention

Control

NO INTERVENTION

Participants in this group will complete the same daily and weekly assessments via the smartphone app but will not have access to the mindfulness or psychoeducation content.

Interventions

Participants will use the smartphone app daily for pain tracking and weekly to engage with mindfulness content and complete additional assessments.

Mindfulness-Based Intervention (MBI)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 to 65
  • Diagnosis of fibromyalgia per Wolfe et al. (2011) criteria
  • Stable medication regimen or medication-free
  • Fluent in English
  • Able to provide informed consent

You may not qualify if:

  • Comorbid pain condition more severe than fibromyalgia
  • Pregnancy or breastfeeding
  • Current psychosis or history of severe psychiatric illness
  • Active suicidal ideation
  • Participation in another therapeutic trial
  • Any condition that may interfere with study compliance as judged by the PI or study coordinator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Brigham and Women's Hospital Department of Anesthesiology

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

FibromyalgiaPainChronic Pain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Asimina Lazaridou, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized controlled trial utilizing a parallel assignment model. Participants are randomly assigned to either the intervention group, which receives a smartphone-based mindfulness video series and daily pain rating prompts, or a control group that receives daily pain tracking only. The intervention is self-guided and delivered remotely via a secure smartphone app. Outcomes are measured at baseline, post-intervention, and 3- and 6-month follow-ups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Anesthesiology

Study Record Dates

First Submitted

June 15, 2025

First Posted

June 24, 2025

Study Start

May 3, 2024

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

January 29, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations